Related Experiment Video
Updated: Jul 15, 2026

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
Published on: July 5, 2017
Methylation suppresses the proteasome-inhibitory function of green tea polyphenols
Kristin R Landis-Piwowar1, Sheng Biao Wan, Richard A Wiegand
1The Prevention Program, Barbara Ann Karmanos Cancer Institute, Department of Pathology, School of Medicine, Wayne State University, Detroit, Michigan, USA.
Abstract:
Under physiological conditions, biotransformation reactions, such as methylation, can modify green tea polyphenols (GTPs) and therefore limit their in vivo cancer-preventive activity. Although a recent study suggested that methylated polyphenols are less cancer-protective, the molecular basis is unknown. We previously reported that ester bond-containing GTPs, for example (-)-epigallocatechin-3-gallate [(-)-EGCG] or (-)-epicatechin-3-gallate [(-)-ECG], potently and specifically inhibit the proteasomal chymotrypsin-like activity. In this study, we hypothesize that methylated GTPs have decreased proteasome-inhibitory abilities. To test this hypothesis, methylated (-)-EGCG and (-)-ECG analogs that can be found in vivo were synthesized and studied for their structure-activity relationships (SARs) using a purified 20S proteasome. The addition of a single methyl group on (-)-EGCG or (-)-ECG led to decreased proteasome inhibition and, as the number of methyl groups increased, the inhibitory potencies further decreased. These SARs were supported by our findings from in silico docking analysis published recently. Previously, we synthesized a peracetate-protected (-)-EGCG molecule, Pro-EGCG (1), to enhance its cellular permeability and stability, and current HPLC analysis confirms conversion of Pro-EGCG (1) to (-)-EGCG in cultured human leukemic Jurkat T cells. Furthermore, in this study, peracetate-protected forms of methylated GTPs were added in intact Jurkat T cells to observe the intracellular effects of methylation. Peracetate-protected, monomethylated (-)-EGCG induced greater cellular proteasome inhibition and apoptosis than did peracetate-protected, trimethylated (-)-EGCG, consistent with the potencies of the parent methylated analogs against a purified 20S proteasome. Therefore, methylation on GTPs, under physiological conditions, could decrease their proteasome-inhibitory activity, contributing to decreased cancer-preventive effects of tea consumption.
Insights
Methylation of green tea polyphenols (GTPs) reduces their ability to inhibit proteasomes, potentially lowering their cancer-preventive effects in the body. This study investigated how methylation impacts GTPs
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Prevention Research
Background:
- Green tea polyphenols (GTPs) show cancer-preventive activity, but biotransformation, like methylation, can alter their efficacy in vivo.
- Previous studies suggest methylated polyphenols are less cancer-protective, but the underlying molecular mechanisms remain unclear.
- Ester bond-containing GTPs, such as (-)-epigallocatechin-3-gallate [(-)-EGCG] and (-)-epicatechin-3-gallate [(-)-ECG], are known potent inhibitors of proteasomal chymotrypsin-like activity.
Purpose of the Study:
- To investigate the hypothesis that methylated GTPs exhibit reduced proteasome-inhibitory abilities compared to their unmethylated counterparts.
- To elucidate the structure-activity relationships (SARs) of methylated GTP analogs concerning proteasome inhibition.
Main Methods:
- Synthesis of methylated (-)-EGCG and (-)-ECG analogs found in vivo.
- Assessment of proteasome-inhibitory abilities using a purified 20S proteasome and in silico docking analysis.
- Evaluation of intracellular effects using peracetate-protected methylated GTPs in cultured human leukemic Jurkat T cells, assessing proteasome inhibition and apoptosis.
Main Results:
- The addition of methyl groups to (-)-EGCG and (-)-ECG progressively decreased their proteasome inhibitory potency.
- Monomethylated (-)-EGCG analogs showed greater intracellular proteasome inhibition and apoptosis induction than trimethylated analogs in Jurkat T cells.
- In silico docking analysis supported the observed SARs, correlating methylation with reduced proteasome inhibition.
Conclusions:
- Methylation of GTPs significantly diminishes their capacity to inhibit proteasomal activity.
- This reduction in proteasome inhibition by methylated GTPs may explain their decreased cancer-preventive effects observed in vivo.
- The findings highlight the critical role of GTP structure modification by methylation in modulating their biological activity and potential therapeutic benefits.
Related Concept Videos
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Abnormal Proliferation
MicroRNAs
MicroRNAs
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Epigenetic Regulation
X-chromosome...
